Modeling Drug-Melanin Interaction with Theoretical Linear Solvation Energy Relationships

Pigment Cell Research

Volumn 10, Issue 5, 1997, Pages 251-256

  Lowrey, Alfred H ^a   Famini, George R ^b   Loumbev, Valery ^c   Wilson, Leland Y ^c   Tosk, Jeffrey M ^c  

^a NAVAL RESEARCH LABORATORY   (United States)

^b SCBRD RT   (United States)

^c LA SIERRA UNIVERSITY   (United States)

Author keywords

Molecular modeling; Movement disorders; Neuromelanin; Neurotoxicology; Parkinson's disease; Pharmacology

Indexed keywords

MELANIN; NEUROLEPTIC AGENT; NEUROMELANIN;

ARTICLE; CHEMICAL STRUCTURE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG EFFECT; EXTRAPYRAMIDAL SYNDROME; HUMAN; METABOLISM; PROTEIN BINDING; SOLUBILITY; STATISTICAL MODEL;

ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; HUMANS; LINEAR MODELS; MELANINS; MODELS, MOLECULAR; PROTEIN BINDING; SOLUBILITY;

EID: 0031242561     PISSN: 08935785     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0749.1997.tb00684.x     Document Type: Article

References (33)

1. Barr-Hamilton, R.M., L.M. Matheson, and D.G. Keay (1991) Ototoxicity of cis-platinum and its relationship to eye colour. J. Laryngol. Otol., 105:7-11.
2. Basu, P.K., I.A. Menon, S.D. Persad, and J.D. Wiltshire (1989) Binding of chlorpromazine to cultured retinal pigment epithelial cells loaded with melanin. Lens Eye Toxic. Res., 6:229-240.
3. Bond, W.S. and G.C. Yee (1980) Ocular and cutaneous effects of chronic phenothiazine therapy. Am. J. Hosp. Pharmacol., 37:74-78.
4. Chan-Palay, V. and E. Asan (1989) Quantitation of catecholamine neurons in the locus coeruleus in human brains of normal young and older adults and in depression. J. Comp. Neurol., 287:357-372.
5. D'Amato, R.J., Z.P. Lipman, and S.H. Snyder (1986) Selectivity of the parkinsonian neurotoxin MPTP: Toxic metabolite binds to neuromelanin. Science 231:987-989.
6. Fager, J.A. (1994) MOPAC automatic data collection and assembly program, Axis Technologies, Inc.
7. Famini, G.R., R.J. Kassel, J.W. King, and L.Y. Wilson (1991) Using theoretical descriptors in quantitative structure activity relationships: Comparison with the molecular transform. Quant. Struct. Act. Relat., 10:344-349.
8. Famini, G.R., W.P. Ashman, A.P. Mickiewicz, and L.Y. Wilson (1992a) Using theoretical descriptors in quantitative structure-activity relationships: Opiate receptor activity by fentanyl-like compounds. Quant. Struct. Act. Relat., 11:162-170.
9. Famini, G.R., C.E. Penski, and L.Y. Wilson (1992b) Using theoretical descriptors in quantitative structure activity relationships: Some physicochemical properties. J. Phys. Org. Chem., 5:395-408.
10. Famini, G.R., B.C. Marquez, and L.Y. Wilson (1993) Using theoretical descriptors in quantitative structure activity relationships: Gas phase acidity. J. Chem. Soc. Perkin Trans., 2:773-783.
11. 2. J. Phys. Org. Chem., 9:539-544.
12. Favaudon, V. and J.M. Lhoste (1975) The kinetics of flavine oxidation-reduction. I. Dismutation in nonaqueous solvent. Biochemistry 14:4731-4738.
13. Hansch, C. (1969) A quantitative approach to biochemical structure-activity relationships. Acc. Chem. Res. 2:232-239.
14. Headley, A.D., S.D. Starnes, L.Y. Wilson, and G.R. Famini (1994) Analysis of solute/solvent interactions for the acidity of acetic acids by theoretical descriptors. J. Org. Chem., 59:8040-8046.
15. Ibrahim, H. and A.F. Aubry (1995) Development of a melanin-based high-performance liquid chromatography stationary phase and its use in the study of drug-melanin binding interactions. Anal. Biochem., 229:272-277.
16. Kamlet, M.J., R.W. Taft, and J.L.M. Abboud (1977) Regarding a generalized scale of solvent polarities. J. Am. Chem. Soc., 99:8325-8327.
17. Kamlet, M.J., R.W. Taft, G.R. Famini, and R.M. Doherty (1987) Linear solvation energy relationships: Local emperical rules - or fundamental laws of chemistry? The dialog continues: A challenge to the chemometricians. Acta Chem. Scand., 41:589-598.
18. Kamlet, M.J., R.M. Doherty, M.H. Abraham, and R.W Taft (1988) Solubility properties in biological media. 12. Regarding the mechanism of nonspecific toxicity or narcosis by organic non-electrolytes. Quant. Struct Act. Relat., 7:71-78.
19. Koppel, I.A. and V.A. Palm (1972) Advances in linear free energy relationships. Chaman, N.B., and J. Shorter, eds. London, Plenum Press.
20. Larsson, B. and H. Tjälve, (1979) Studies on the mechanism of drugbinding to melanin. Biochem. Pharmacol., 28:1181-1187.
21. Larsson, B.S. (1993) Interaction between chemicals and melanin. Pigment Cell Res., 6:127-133.
22. Leonard, J.M. and G. R. Famini (1989) A user's guide to the molecular modeling and display system, CDREC-TR-030, US Army Chemical Research, Development and Engineering Center, Aberdeen Proving Ground, MD.
23. Lohr, J.B. and D.V. Jeste (1988) Locus ceruleus morphometry in aging and schizophrenia. Acta. Psychiatr. Scand., 77:689-697.
24. Potts, A.M. (1964) The reaction of uveal pigment in vitro with polycyclic compounds. Invest. Opthalm., 3:405-416.
25. Radswanska, A., T. Frackowiak, H. Ibrahim, A.F. Aubrey, and R. Kaliszan (1995) Chromatographic modeling of interactions between melanin. Biomed. Chromat., 9:233.
26. Raghaven, P.R., P.A. Zane, and S.L. Tripp (1990) Calculation of drug-melanin binding energy using molecular modeling. Experientia, 46:77-80.
27. Salazar-Bookaman, M.M., I. Wainer, and P.N. Patil (1994) Relevance of drug-melanin interactions to ocular pharmacology and toxicology. J. Ocul. Pharmacol., 10:217-239.
28. Sarna, T. (1992) Properties and function of the ocular melanin: A photobiophysical view. J. Photochem. Photobiol., 12:215-258.
29. Schmitz, S., P.D. Thomas, T.M. Allen, M.J. Poznansky, and K. Jimbow (1995) Dual role of melanins and melanin precursors as photoprotective and phototoxic agents: Inhibition of ultraviolet radiation-induced lipid peroxidation.Photoehem. Photobiol., 61:650-655.
30. Steiner, K., K.U. Buhring, and E. Merck (1990) The melanin binding of bisoprolol and its toxicological relevance. Lens Eye Toxic. Res., 7:319-333.
31. Stepien, K.B. and T. Wilczok (1982) Studies of the mechanism of chloroquine binding to synthetic DOPA-melanin. Biochem. Pharmacol., 31:3359-3365.
32. -3 with L-DOPA melanin on T1 and T2 relaxation times determined by magnetic resonance imaging. Magn. Reson. Med., 26:40-45.
33. Wilson, L.Y. and G.R. Famini (1991) Using theoretical descriptors in quantitative structure activity relationships: Some toxicological indices. J. Med. Chem., 34:1668-1674.